Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2023 - 2026)
Advanced Biomed (ADVB) posted Depreciation & Amortization (CF) of $9326.0 for Q1 2026, up 172.54% sequentially from -$12857.0 in Q4 2025, and down 58.56% YoY from $22507.0 in Q1 2025.
Advanced Biomed (ADVB) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Advanced Biomed has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $9326.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 58.56% year-over-year to $9326.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320326.0 (up 44.37% YoY) and the FY2025 annual result came in at $343830.0, down 13.96% from the prior year.
- Depreciation & Amortization (CF) grew to $9326.0 in Q1 2026 per ADVB's latest filing, from -$12857.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $275865.0 in Q2 2025 and troughed at -$56760.0 in Q4 2024.
- A 4-year average of $68311.7 and a median of $52945.5 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) tumbled 198.03% in 2024, then jumped 79.24% in 2025.
- Over 4 years, Depreciation & Amortization (CF) stood at $57899.0 in 2023, then sank by 198.03% to -$56760.0 in 2024, then surged by 77.35% to -$12857.0 in 2025, then surged by 172.54% to $9326.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $9326.0, -$12857.0, and $47992.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 331.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 196.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 41.05 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 67.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 292.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.52 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 51.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 13.30 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 146.00 Mn |
| 10 | Advanced Biomed | 10.46 Mn | 10.46 Mn | - | 9,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,326.00 |
| Mar 31, 2026 | 9,326.00 |
| Dec 31, 2025 | -12,857.00 |
| Dec 31, 2025 | -12,857.00 |
| Sep 30, 2025 | 47,992.00 |
| Sep 30, 2025 | 47,992.00 |
| Jun 30, 2025 | 275,865.00 |
| Jun 30, 2025 | 275,865.00 |
| Mar 31, 2025 | 22,507.00 |
| Mar 31, 2025 | 22,507.00 |
| Dec 31, 2024 | -56,760.00 |
| Dec 31, 2024 | -56,760.00 |
| Sep 30, 2024 | 102,218.00 |
| Sep 30, 2024 | 102,218.00 |
| Jun 30, 2024 | 153,911.00 |
| Jun 30, 2024 | 153,911.00 |
| Mar 31, 2024 | 83,016.00 |
| Mar 31, 2024 | 83,016.00 |
| Dec 31, 2023 | 57,899.00 |
| Dec 31, 2023 | 57,899.00 |